Real-world Experience of Abrocitinib on Difficult-to-treat Hand Eczema in Chinese Patients

被引:0
|
作者
Li, Yiting [1 ]
Tan, Xi [1 ]
Nie, Shu [1 ]
Tian, Xin [2 ,3 ]
Wu, Zhouwei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Dermatol, 100 Haining Rd, Shanghai 200080, Peoples R China
[2] Guangzhou Med Univ, Inst Dermatol, Guangzhou, Peoples R China
[3] Guangzhou Inst Dermatol, Dept Dermatol, 56 Hengfu Rd, Guangzhou 510095, Peoples R China
关键词
D O I
10.2340/actadv.v104.39822
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Real-world effectiveness of abrocitinib treatment in patients with difficult-to-treat atopic dermatitis
    Olydam, J. I.
    Schloesser, A. R.
    Custurone, P.
    Nijsten, T. E. C.
    Hijnen, D.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (12) : 2537 - 2542
  • [2] Abrocitinib for difficult-to-treat atopic dermatitis
    Lorenz, Judith
    [J]. AKTUELLE DERMATOLOGIE, 2023, 49 (12) : 546 - 546
  • [3] Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience
    Cacciapuoti, Sara
    Potestio, Luca
    Lucia, Gallo
    Letizia, Musumeci Maria
    Caldarola, Giacomo
    D'Amico, Domenico
    Francesco, Caudullo
    Valeria, Papaianni
    De Simone, Clara
    Peris, Ketty
    Megna, Matteo
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
  • [4] Ceftolozane/tazobactam for difficult-to-treat Gram-negative infections: A real-world tertiary hospital experience
    Ronda, Mar
    Perez-Recio, Sandra
    Gonzalez Laguna, Monica
    Tubau Quintano, Maria de la Fe
    Llop Talaveron, Josep
    Soldevila-Boixader, Laura
    Carratala, Jordi
    Cuervo, Guillermo
    Padulles, Ariadna
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (07) : 932 - 939
  • [5] Upadacitinib treatment in a real-world difficult-to-treat atopic dermatitis patient cohort
    Schloesser, Anne R.
    Boeijink, Neill
    Olydam, Jill
    Nijsten, Tamar E. C.
    Hijnen, Dirkjan
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (02) : 384 - 392
  • [6] UPADACITINIB TREATMENT IN A REAL-WORLD DIFFICULT-TO-TREAT ATOPIC DERMATITIS PATIENT COHORT
    Schlosser, Anne Rosalie
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 29 - 29
  • [7] Characteristics of difficult-to-treat axial spondyloarthritis: Results of a real-world multicentric study
    Philippoteaux, Cecile
    Delepine, Thibaut
    Cailliau, Emeline
    Philippe, Peggy
    Taisne, Nicolas
    Pascart, Tristan
    Cortet, Bernard
    Paccou, Julien
    Flipo, Rene-Marc
    Letarouilly, Jean-Guillaume
    [J]. JOINT BONE SPINE, 2024, 91 (02)
  • [8] INCIDENCE RATES OF DIFFICULT-TO-TREAT RHEUMATOID ARTHRITIS IN REAL-WORLD CLINICAL PRACTICE
    Hirano, Y.
    Hasegawa, J.
    Kosugiyama, H.
    Kihira, D.
    Hattori, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 455 - 455
  • [9] Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry
    Kamphuis, Esme
    Boesjes, Celeste M.
    Loman, Laura
    Kamsteeg, Marijke
    Haeck, Inge
    van Lynden-van Nes, Anneke M. T.
    Politiek, Klaziena
    van der Gang, Liana F.
    de Graaf, Marlies
    de Bruin-Weller, Marjolein S.
    Schuttelaar, Marie L. A.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2024, 104 : adv19454
  • [10] Real-world study comparing the efficacy of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis
    Hayashi, Shinya
    Nakano, Naoki
    Tsubosaka, Masanori
    Kamenaga, Tomoyuki
    Kuroda, Yuichi
    Matsumoto, Tomoyuki
    Yamada, Hirotaka
    Nishimra, Keisuke
    Ueda, Yo
    Saegusa, Jun
    Kuroda, Ryosuke
    [J]. CLINICAL RHEUMATOLOGY, 2024,